COPD pharmacology

Inhaled corticosteroid responses in COPD: do mast cells hold the answer?
Andrew Higham, Dave Singh

Thorax Dec 2022, thorax-2022-219534; DOI: 10.1136/thorax-2022-219534
Inventing the wheel: understanding heterogeneity of response to skeletal muscle dysfunction interventions in women with COPD
Merry-Lynn N McDonald

Thorax Nov 2022, thorax-2022-219586; DOI: 10.1136/thorax-2022-219586
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial
Divya Mohan, Harry Rossiter, Henrik Watz, Charles Fogarty, Rachael A Evans, William Man, Maggie Tabberer, Misba Beerahee, Subramanya Kumar, Helen Millns, Sebin Thomas, Ruth Tal-Singer, Alan J Russell, Marie Claire Holland, Chika Akinseye, David Neil, Michael I Polkey

Thorax Oct 2022, thoraxjnl-2021-218360; DOI: 10.1136/thorax-2021-218360
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
Safa Ahmadian, Don D Sin, Larry Lynd, Mark Harrison, Mohsen Sadatsafavi

Thorax Nov 2022, 77 (11) 1079-1087; DOI: 10.1136/thoraxjnl-2021-217962
Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study
Matthew J Pavitt, Adam Lewis, Sara C Buttery, Bernadette O Fernandez, Monika Mikus-Lelinska, Winston A S Banya, Martin Feelisch, Michael I Polkey, Nicholas S Hopkinson

Thorax Oct 2022, 77 (10) 968-975; DOI: 10.1136/thoraxjnl-2021-217147
Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review
Vishanna Balbirsingh, Andrea S Mohammed, Alice M Turner, Michael Newnham

Thorax Sep 2022, 77 (9) 939-945; DOI: 10.1136/thoraxjnl-2021-218333
Inhaled corticosteroids in COPD: risk and benefits
Christer Janson

Thorax Jun 2022, 77 (6) 530-531; DOI: 10.1136/thoraxjnl-2021-217930
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from patients with COPD
Koralia Paschalaki, Christos Rossios, Charis Pericleous, Mairi MacLeod, Stephen Rothery, Gavin C Donaldson, Jadwiga A Wedzicha, Vassilis Gorgoulis, Anna M Randi, Peter J Barnes

Thorax Jun 2022, 77 (6) 616-620; DOI: 10.1136/thoraxjnl-2020-216807
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
Benjamin David, Mona Bafadhel, Leo Koenderman, Antony De Soyza

Thorax Feb 2021, 76 (2) 188-195; DOI: 10.1136/thoraxjnl-2020-215167
Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study
Daniel B Rasmussen, Uffe Bodtger, Morten Lamberts, Christian Torp-Pedersen, Gunnar Gislason, Peter Lange, Magnus T Jensen

Thorax Nov 2020, 75 (11) 928-933; DOI: 10.1136/thoraxjnl-2019-214206

Main menu

COPD pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COPD pharmacology

Pages